ATRECA INC's ticker is BCEL and the CUSIP is 04965G109. A total of 47 filers reported holding ATRECA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,678 | -79.7% | 6,431 | -23.7% | 0.00% | – |
Q2 2023 | $8,264 | +12.7% | 8,433 | +31.1% | 0.00% | – |
Q1 2023 | $7,331 | +106.7% | 6,431 | +45.1% | 0.00% | – |
Q4 2022 | $3,546 | – | 4,433 | +7288.3% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 60 | -98.7% | 0.00% | – |
Q2 2022 | $8,000 | -65.2% | 4,581 | -38.3% | 0.00% | – |
Q1 2022 | $23,000 | -20.7% | 7,422 | -23.5% | 0.00% | – |
Q4 2021 | $29,000 | +26.1% | 9,703 | +158.0% | 0.00% | – |
Q3 2021 | $23,000 | -72.3% | 3,761 | -61.3% | 0.00% | – |
Q2 2021 | $83,000 | -82.9% | 9,729 | -69.2% | 0.00% | – |
Q1 2021 | $484,000 | +2320.0% | 31,548 | +2419.8% | 0.00% | – |
Q4 2020 | $20,000 | +122.2% | 1,252 | +101.0% | 0.00% | – |
Q3 2020 | $9,000 | -94.2% | 623 | -91.5% | 0.00% | – |
Q2 2020 | $156,000 | +4.0% | 7,318 | -19.0% | 0.00% | – |
Q1 2020 | $150,000 | +0.7% | 9,039 | -6.4% | 0.00% | – |
Q4 2019 | $149,000 | +104.1% | 9,653 | +61.9% | 0.00% | – |
Q3 2019 | $73,000 | +160.7% | 5,961 | +301.1% | 0.00% | – |
Q2 2019 | $28,000 | – | 1,486 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,320,880 | $2,100,000 | 1.66% |
CM Management, LLC | 249,282 | $391,000 | 0.44% |
Aisling Capital Management LP | 387,653 | $609,000 | 0.40% |
Boxer Capital, LLC | 2,202,333 | $3,458,000 | 0.19% |
Samsara BioCapital, LLC | 396,835 | $623,000 | 0.14% |
Redmile Group, LLC | 800,306 | $1,256,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 191,442 | $301,000 | 0.04% |
Baker Brothers Advisors | 3,532,760 | $5,546,000 | 0.04% |
Cormorant Asset Management, LP | 319,057 | $501,000 | 0.04% |
Rock Springs Capital Management LP | 462,530 | $726,000 | 0.02% |